Share
13 min read
communityEvidence-based

What you missed in The Phoenix Community in Sep-Oct

Release of our app, New features, Partnerships, 101 topics discussed, and more!

T
· Reviewed by Dr. Kevin Tran, PharmD
What you missed in The Phoenix Community in Sep-Oct

Key takeaways · TL;DR

In September and October 2025, Phoenix launched its dedicated APOE4 member app, opened a photobiomodulation research partnership with Neuronic, and facilitated 101 community discussions covering p-tau217 testing, Stanford memory restoration research, shingles vaccine Alzheimer risk reduction, and the gut-brain axis for APOE4 carriers.

Definition

A personalized brain health metric generated by the Phoenix app analyzing 100+ blood biomarkers against APOE4-specific reference ranges.

The Phoenix Score aggregates lipid markers, inflammatory biomarkers, metabolic health, and Alzheimer-specific labs into a trend-tracked dashboard with actionable recommendations.

Definition

An AI tool in the Phoenix app that identifies which interventions produced measurable changes in a members biomarkers over time.

Attribution Wizard solves the problem of not knowing which supplement or lifestyle change actually moved your numbers by correlating intervention logs with blood test results.

Discussion

Join the conversation

Your email will never be published. Be respectful and constructive.

FAQ

Frequently asked questions.

What features are in the new Phoenix app for APOE4 carriers?
The Phoenix app offers the largest APOE4-specific supplement library with efficacy ratings, side effect tracking, brand recommendations, and daily adherence calendars. It provides monthly and daily check-ins with over 20 health metrics, trend analysis, symptom tracking, and cognitive function monitoring. In development are Blood Test Analysis that uploads lab PDFs for AI analysis of 100+ biomarkers with APOE4-specific ranges, a unified My Stack interventions dashboard, and an Attribution Wizard that uses AI to connect specific interventions to biomarker changes.
What is the Neuronic photobiomodulation study for APOE4 carriers?
Phoenix partnered with Neuronic to launch an exclusive red light therapy research case study for APOE4 carriers. Cohort 1 enrollment closed October 21 with a hard deadline of October 31 for helmet delivery and protocol start. Members use the device for a 12-week protocol that evaluates whether photobiomodulation benefits brain health outcomes including inflammatory markers and cognitive function. The partnership illustrates how community scale unlocks research access that individual APOE4 carriers cannot obtain alone.
What vaccine research showed Alzheimer risk reduction for APOE4 carriers?
Phoenix community discussions in September and October covered research showing that combined shingles and RSV vaccines were associated with more than a 30 percent reduction in Alzheimer disease risk, with particularly strong protective effects observed in women. Members dissected the mechanisms, which are thought to involve modulation of neuroinflammation and reactivation of latent viral infections implicated in neurodegeneration. This built on earlier findings that the shingles vaccine alone reduces dementia incidence.
Why is the gut-brain axis important for APOE4 carriers?
Discussions highlighted how APOE4 carriers have distinct gut microbiome composition that influences brain inflammation and amyloid accumulation. Members explored fibrinogen role in brain inflammation, how gut bacteria produce metabolites that cross the blood-brain barrier, and practical dietary interventions. The gut-brain connection emerged as a priority lever because APOE4 carriers may experience faster toxin transport from gut to brain, making microbiome optimization through fiber, fermented foods, and targeted probiotics a preventive strategy.
🚀 Ready to Stop Reading About It and Start Living It?
Every day you wait is another day of insights you're missing, connections you're not making, and optimizations you're not implementing. The members who joined us months ago are now 10+ interventions ahead of where they started. They're negotiating better testing prices. They're enrolled in exclusive studies. They're part of something bigger than themselves.
Keep reading

Related protocols.